About the Company
We do not have any company description for Ikena Oncology, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $IKNA News
Ikena Oncology gets grant for cancer treatment method using compounds of formula i
Discover the groundbreaking patent by Ikena Oncology Inc for treating cancer with specific compounds and methods. Learn how this innovative approach targets cancers with increased TEAD expression, ...
Down -29.05% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround
A downtrend has been apparent in Ikena Oncology, Inc. (IKNA) lately with too much selling pressure. The stock has declined 29.1% over the past four weeks. However, given the fact that it is now in ...
The -13.88% Decline of Ikena Oncology Inc’s (IKNA) Stock in the Past Quarter
IKNA stock has gone up by 1.47%, with a monthly decline of -0.72% and a quarterly plunge of -31.00%. The volatility ratio for the week is 9.46%, and the volatility levels for the last 30 days are 7.86 ...
Ikena Oncology Inc IKNA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Ikena Oncology to Present at the Stifel 2024 Virtual Targeted Oncology Forum
The webcast link will stream the presentation and will be archived for 30 days following the end of the conference, accessible above. The presentation webcast can also be accessed by visiting the ...
The Analyst Landscape: 4 Takes On Ikena Oncology
Discovering Ikena Oncology: A Closer Look Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread ...
Ikena Oncology Inc IKNA
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Analyst Landscape: 4 Takes On Ikena Oncology
Stay informed and make well-judged decisions with the assistance of our Ratings Table. Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that ...
Ikena Oncology Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
IKNA Ikena Oncology, Inc.
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
Ikena Oncology, Inc. (IKNA)
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
Ikena Oncology Inc (IKNA)
Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” “Company”), a targeted oncology company forging new territory in patient-directed cancer treatment, today ...
Loading the latest forecasts...